Vivos Therapeutics, Inc. (VVOS)

NASDAQ: VVOS · Real-Time Price · USD

1.350

-0.060 (-4.26%)

At close: Mar 3, 2026, 4:00 PM EST

1.300

-0.050 (-3.70%)

After-hours: Mar 3, 2026, 7:25 PM EST

Vivos Therapeutics Analyst Ratings

Total Analysts

2

Consensus Rating

Strong Buy

Price Target

$6.25

Upside

+362.96%

Ratings History

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.5 → $5.5	Strong Buy	Maintains	$6.5 → $5.5	+307.41%	Dec 3, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+418.52%	Nov 17, 2025
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.2 → $6.5	Strong Buy	Maintains	$6.2 → $6.5	+381.48%	Sep 9, 2025
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.6 → $6.2	Strong Buy	Maintains	$6.6 → $6.2	+359.26%	Apr 15, 2025
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Reiterates $6.6	Strong Buy	Reiterates	$6.6	+388.89%	Nov 20, 2024
Scott Henry Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $8.25 → $6	Strong Buy	Maintains	$8.25 → $6	+344.44%	Nov 19, 2024
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.4 → $6.6	Strong Buy	Maintains	$6.4 → $6.6	+388.89%	Aug 20, 2024
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Initiates $63	Strong Buy	Initiates	$63	+4,529.63%	Jan 17, 2023
Scott Henry Roth Capital	Roth Capital	Strong Buy Maintains $275 → $250	Strong Buy	Maintains	$275 → $250	+18,418.52%	Aug 13, 2021
Scott Henry Roth Capital	Roth Capital	Strong Buy Maintains $300 → $275	Strong Buy	Maintains	$300 → $275	+20,270.37%	May 18, 2021
Alexander Nowak Craig-Hallum	Craig-Hallum	Strong Buy Initiates $300	Strong Buy	Initiates	$300	+22,122.22%	Jan 11, 2021
Scott Henry Roth Capital	Roth Capital	Strong Buy Initiates $300	Strong Buy	Initiates	$300	+22,122.22%	Jan 5, 2021